GOSSVSNRIX• 28 Days (Normalized)
GOSS vs NRIX (Gossamer Bio Inc. vs Nurix Therapeutics Inc.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.73
+6867.53%
Gossamer Bio Inc.
Normalized Baseline0.00%
NRIX Performance $25.1
-7.21%
Nurix Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+6874.74%
GOSS outperforming by 6874.74%
GOSSNRIX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS NRIX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | GOSS Price | GOSS Gain (%) | NRIX Price | NRIX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.73 | +6867.53% | $25.10 | -7.21% | +6874.74% |
| Sep 10, 2026 | $11.36 | +7276.62% | $25.81 | -4.58% | +7281.20% |
| Sep 09, 2026 | $12.80 | +8211.69% | $26.26 | -2.92% | +8214.61% |
| Sep 08, 2026 | $14.40 | +9250.65% | $26.13 | -3.40% | +9254.05% |
| Sep 04, 2026 | $14.00 | +8990.91% | $26.14 | -3.36% | +8994.27% |
| Sep 03, 2026 | $14.05 | +9022.08% | $25.32 | -6.40% | +9028.48% |
| Sep 02, 2026 | $0.17 | +12.34% | $25.82 | -4.55% | +16.89% |
| Sep 01, 2026 | $0.17 | +8.44% | $26.04 | -3.73% | +12.17% |
| Aug 31, 2026 | $0.17 | +10.39% | $25.78 | -4.70% | +15.09% |
| Aug 28, 2026 | $0.17 | +10.39% | $26.21 | -3.11% | +13.50% |
| Aug 27, 2026 | $0.17 | +10.39% | $26.88 | -0.65% | +11.04% |
| Aug 26, 2026 | $0.17 | +12.99% | $26.71 | -1.26% | +14.25% |
| Aug 25, 2026 | $0.21 | +33.12% | $26.95 | -0.37% | +33.49% |
| Aug 24, 2026 | $0.18 | +13.64% | $26.27 | -2.88% | +16.52% |
| Aug 21, 2026 | $0.16 | +0.65% | $26.72 | -1.22% | +1.87% |
Page 1 of 2